Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Accumulated Depreciation & Amortization (2016 - 2017)

Armata Pharmaceuticals' Accumulated Depreciation & Amortization history spans 4 years, with the latest figure at $1.2 million for Q4 2017.

  • For Q4 2017, Accumulated Depreciation & Amortization rose 25.54% year-over-year to $1.2 million; the TTM value through Dec 2017 reached $1.2 million, up 25.54%, while the annual FY2017 figure was $1.2 million, 25.54% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2017 was $1.2 million at Armata Pharmaceuticals, up from $932000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.2 million in Q4 2017 and bottomed at -$127000.0 in Q4 2014.
  • The 4-year median for Accumulated Depreciation & Amortization is $641500.0 (2013), against an average of $581500.0.
  • The largest annual shift saw Accumulated Depreciation & Amortization plummeted 136.18% in 2014 before it rose 25.54% in 2017.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $351000.0 in 2013, then tumbled by 136.18% to -$127000.0 in 2014, then skyrocketed by 833.86% to $932000.0 in 2016, then increased by 25.54% to $1.2 million in 2017.
  • Per Business Quant, the three most recent readings for ARMP's Accumulated Depreciation & Amortization are $1.2 million (Q4 2017), $932000.0 (Q4 2016), and -$127000.0 (Q4 2014).